<unk>  refers to a regimen consisting of fludarabine, mitoxantrone and dexamethasone used to treat indolent non-Hodgkin's lymphoma and rituximab in combination is used for the treatment of advanced follicular lymphoma
FN-D regimen
FMC-R regimen
RCD regimen
ICE-R regimen
ACVBP-R regimen
MINE-R regimen
FEC regimen
DCEP regimen